PUBLISHER: BCC Research | PRODUCT CODE: 1799444
PUBLISHER: BCC Research | PRODUCT CODE: 1799444
The global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
The North American market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $6.0 billion in 2025 to reach $8.9 billion by the end of 2030, at a CAGR of 8.3% from 2025 to 2030.
The Asia-Pacific market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $2.9 billion in 2025 to reach $4.6 billion by the end of 2030, at a CAGR of 9.7% from 2025 to 2030.
This report analyzes the market for chromatography in pharmaceuticals and biotechnology and covers its competitive landscape. It analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. It offers profiles of several leading companies in this market, including details about their revenues, product portfolios and recent activities. The report will enable companies in the chromatography industry to make informed decisions about the production and licensing of goods and services.
For this analysis, the chromatography in pharmaceuticals and biotechnology market is divided by product type into two segments: chromatography instruments and chromatography reagents. The regents market is further segmented by technology into the following subsegments: liquid chromatography, gas chromatography, supercritical fluid chromatography and thin-layer chromatography. In addition, the report covers subtypes of liquid chromatography such as high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC), affinity chromatography, ion exchange chromatography and others (including size exclusion, hydrophobic and flash chromatography). The chromatography in pharmaceuticals and biotechnology market is also segmented by application into the following segments: drug discovery and development, pharmaceutical analysis, downstream processing, proteomics, diagnostics, and metabolomics.
The report also features a regional market analysis. For this analysis, the market for chromatography in pharmaceuticals and biotechnology is segmented into the following regions: North America, Europe, Asia-Pacific, Middle East and Africa (MEA) and South America. The report also provides country-level analyses within the regional markets and market segments. The North American region is segmented into the U.S., Canada and Mexico, while the South American region is segmented into Brazil, Argentina and the rest of South America. The major European countries covered are Germany, France, the U.K., Italy and Spain. The rest of Europe, includes Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden and Russia, and is considered as its own subsegment of the European region. Similarly, the major Asia-Pacific countries covered are Japan, China and India, with the rest of Asia-Pacific that includes Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, the Philippines, South Korea and Indonesia. It is considered as its own subsegment of the Asia-Pacific region.
The base year for the study is 2024. and the market projections are given for 2025 through 2030, including compound annual growth rates (CAGRs) for the forecast period.